2361

Sinohealth Holdings Limited Stock Price

SEHK:2361 Community·HK$1.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

2361 Share Price Performance

HK$3.60
-0.90 (-20.00%)
HK$3.60
-0.90 (-20.00%)
Price HK$3.60

2361 Community Narratives

There are no narratives available yet.

Recent 2361 News & Updates

Sinohealth Holdings (HKG:2361) Will Pay A Larger Dividend Than Last Year At CN¥0.12

Jun 18
Sinohealth Holdings (HKG:2361) Will Pay A Larger Dividend Than Last Year At CN¥0.12

Sinohealth Holdings (HKG:2361) Has Announced That It Will Be Increasing Its Dividend To CN¥0.12

Apr 24
Sinohealth Holdings (HKG:2361) Has Announced That It Will Be Increasing Its Dividend To CN¥0.12

Sinohealth Holdings Limited Key Details

CN¥392.1m

Revenue

CN¥165.6m

Cost of Revenue

CN¥226.5m

Gross Profit

CN¥132.8m

Other Expenses

CN¥93.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.23
Gross Margin
57.77%
Net Profit Margin
23.90%
Debt/Equity Ratio
0%

Sinohealth Holdings Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet and fair value.

0 Risks
1 Reward

About 2361

Founded
2007
Employees
756
CEO
Yushu Wu
WebsiteView website
ir.sinohealth.cn

Sinohealth Holdings Limited provides healthcare solutions for sales and marketing needs of medical product manufacturer clients in Mainland China, the Netherland, England, Hong Kong, Singapore, and internationally. It engages in the research and development, and provision of data insight solutions, data-driven publications and events, and software as a service (SaaS) products; research and development, and operation of Smart Medical Cloud under the business line of SaaS products; management of marketing and promotion services of medicine; operation of SaaS products; provision of internet information and internet data center services; production and publication of videos; and foreign-related market research business. The company also offers precision marketing solutions; and consulting and marketing services. It serves various fields, such as pharmaceutical industry, retail pharmacies, and physical examination and hospitals. The company was founded in 2007 and is headquartered in Guangzhou, China.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 1.8%
  • 3 Months: 18.3%
  • 1 Year: 24.1%
  • Year to Date: 26.2%
Over the past 7 days, the market has risen 1.8% with the Industrials sector contributing the most to the gain. In the last year, the market has climbed 24%. Looking forward, earnings are forecast to grow by 27% annually. Market details ›